Since the first description of laparoscopic splenectomy (LS) in 1991, this technique has been adopted
as the standard procedure for most indications for splenectomy throughout the world. The utility of LS in the
treatment of hematologic diseases such as hereditary spherocytosis, immune thrombocytopenic purpura, and
autoimmune hemolytic anemia is well established. LS has become the gold standard approach for normal or
slightly enlarged spleens and is currently considered the procedure of choice. The benefits of laparoscopic
removal of the spleen are evident to patients and surgeons alike. This approach is superior to open splenectomy in
terms of postoperative pain, shorter postoperative hospital stay, perioperative complications, and an improved
cosmetic result. Additionally, the period of convalescence is brief, with an early return to work or normal
activities. The results of large series around the world are similar, with an operating time of between 60 and 90
minutes, hospital stay of between 1 and 2 days and morbidity of less than 10% [1,2,3,4,5].